PRI Company Update: Prapela Awarded $1M from the Ohio Opioid Technology Challenge

We are excited to share that Prapela, Inc. has been awarded $1,000,000 for its efforts to improve the treatment of opioid-exposed newborns in the Ohio Opioid Technology Challenge.  Prapela SVS is a gentle, random vibration that improves breathing, heart rate, and relaxation in newborns as they withdraw from opioids they were exposed to during pregnancy. Read more here.

Congratulations, Prapela!!

Share:

more insights

Cami Martin, MD, MS, Chief Scientific Officer of the Charles Hood Foundation

The Charles H. Hood Foundation Welcomes Dr. Camilia Martin as Chief Scientific Officer

The Charles H. Hood Foundation is delighted to announce that Camilia (“Cami”) R. Martin, MD, MS, has joined the Foundation as Chief Scientific Officer. In this leadership role, Dr. Martin will steward and advance the Hood Foundation’s child health research portfolio, overseeing pediatric research awards and serving as a strategic scientific partner across initiatives, including the Hood Pediatric Innovation Hub.

Read more >